SWOG GU Oncology Presentation: Dr. Brian Chapin

True

False

Stage migration in evaluation of prostate cancer patients

Changes in clinical management of patients with biochemical recurrence

Identification of disease sites not seen on conventional imaging

Improvement in overall survival for men with metastatic prostate cancer

Provide a cure men with metastatic prostate cancer

Improve survival in men with metastatic prostate cancer

Be associated with increased toxicity compared to standard of care alone

Demonstrate a signal of effect based on progression free survival

A standard of care option for men with metastatic prostate cancer

Is supported by Phase 3 randomized trial data

Is under investigation in prospective clinical trials

Is a superior local therapy compared to radiation

Only present after selection pressures of ADT

Only present at the time of castration resistant prostate cancer (CRPC)

Found in de novo metastatic prostate cancer

A good prognostic funding in men with metastatic prostate cancer

Yes

Name and Degree

Title

Institutional Affiliation

Date of Birth, Month and Date only

If Applying for ABIM credit, please enter your ABIM Learner ID

Are you a SWOG Member? Yes or No

Date of Activity Completion